Skip to main navigation
Great Science. Great Medicine
ChemoCentryx
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact Us
  • PRODUCT
  • Pipeline
    • Overview
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-Oncology and Other Therapeutic Areas
      • Preclinical Candidates
    • Other Inflammatory and Autoimmune Diseases
      • Vercirnon
      • CCX507
      • Th17 Driven Diseases and CCR6
  • Diseases
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-oncology
    • Other Inflammatory and Autoimmune Diseases
  • Science
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Job Postings
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact Us
  • Product
  • Pipeline
    • Overview
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-Oncology and Other Therapeutic Areas
      • Preclinical Candidates
    • Other Inflammatory and Autoimmune Diseases
      • Vercirnon
      • CCX507
      • Th17 Driven Diseases and CCR6
  • Diseases
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-oncology
    • Other Inflammatory and Autoimmune Diseases
  • Science
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Job Postings
ChemoCentryx
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Advisory Board
    • Strategic Partners
    • In the Community
    • Contact
  • Pipeline
  • Diseases
    • Chronic Kidney Disease
    • Orphan and Rare Diseases
    • Other Inflammatory and Autoimmune Diseases
    • Immuno-oncology
  • Science
    • Overview
    • Complement System and Rare Diseases
    • Chemokines and Inflammation/Autoimmune Disorders
    • Chemokines and Immuno-oncology
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Job Postings
    • Benefits
Go to...
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Advisory Board
    • Strategic Partners
    • In the Community
    • Contact
  • Pipeline
  • Diseases
    • Chronic Kidney Disease
    • Orphan and Rare Diseases
    • Other Inflammatory and Autoimmune Diseases
    • Immuno-oncology
  • Science
    • Overview
    • Complement System and Rare Diseases
    • Chemokines and Inflammation/Autoimmune Disorders
    • Chemokines and Immuno-oncology
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Job Postings
    • Benefits

Investors

Events & Presentations

Presentations

Date Documents
01/12/22
  • Add Files
    Corporate Presentation January 2022 2.9 MB
12/21/20
  • Add Files
    Topline Results of ACCOLADE Trial of Avacopan for C3 Glomerulopathy (C3G) 483.7 KB

Upcoming Events

Date Event Details Remind Me
Summary Toggle 05/24/22 12:30 PM EDT

H.C. Wainwright Global Investment Conference

Click here for Webcast
Add to Outlook
Add to Google Calendar

Archived Events

Date Event Details
Summary Toggle 05/05/22 5:00 PM EDT

ChemoCentryx, Inc. First Quarter 2022 Financial Results Conference Call

Click here for Webcast

Supporting Materials

View Presentation 1.9 MB
Summary Toggle 03/01/22 5:00 PM EST

ChemoCentryx, Inc. Fourth Quarter 2021 Financial Results Conference Call

Click here for Webcast

Supporting Materials

View Presentation 1.3 MB
Summary Toggle 02/16/22 5:00 PM EST

11th Annual SVB Leerink Global Healthcare Conference

Click here for Webcast
Summary Toggle 01/12/22 4:30 PM EST

40th Annual J.P. Morgan Healthcare Conference

Click here for Webcast
Summary Toggle 01/10/22 7:00 AM EST

H.C. Wainwright Virtual BioConnect Conference

Click here for Webcast

Investor Relations

  • Overview
  • News Releases
  • Events & Presentations
  • Financials & Filings
    • SEC Filings
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Committee Composition
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Printed Materials
  • Email Alerts Subscription
  • Snapshot
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

COMPANY

  • Overview
  • Management Team
  • Board of Directors
  • Contact Us

PRODUCT

PIPELINE

  • Overview
  • Orphan and Rare Diseases
  • Chronic Kidney Disease
  • Immuno-Oncology and Other Therapeutic Areas
  • Other Inflammatory and Autoimmune Diseases

Diseases

  • Orphan and Rare Diseases
  • Chronic Kidney Disease
  • Immuno-Oncology
  • Other Inflammatory and Autoimmune Diseases

SCIENCE

INVESTORS

Careers

  • Culture
  • Benefits
  • Job Postings

CONTACT INFORMATION

835 Industrial Ave. Suite 600
San Carlos, CA 94070

Phone: +1.650.210.2900

Fax: +1.650.210.2910

Email: info@chemocentryx.com

© 2022 ChemoCentryx, Inc. | Legal and Privacy